Biden Administration Facing Renewed Pressure to Legalize Cannabis
FDA Law Blog
AUGUST 2, 2022
As a reminder, cannabis remains a schedule I substance under the federal Controlled Substances Act (“CSA”), which by definition means it does not have an accepted medical use in treatment in the United States and thus cannot be legally sold or marketed for any purpose. Cole providing guidance to U.S. 21 U.S.C. § 812(b)(1).
Let's personalize your content